Prevail Therapeutics
Why Robinhood?
You can watch PRVL and buy or sell other stocks, ETFs, and their options commission-free!About PRVL
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases.
PRVL Key Statistics
Stock Snapshot
As of today, Prevail Therapeutics(PRVL) shares are valued at $23.00. The company's market cap stands at 787.7M, with a P/E ratio of -10.03.
On 2026-10-12, Prevail Therapeutics(PRVL) stock opened at —, reached a high of —, and a low of —.
Prevail Therapeutics(PRVL) shares are trading with a volume of 0, against a daily average of 1.19M.
In the last year, Prevail Therapeutics(PRVL) shares hit a 52-week high of $23.35 and a 52-week low of $9.02.
In the last year, Prevail Therapeutics(PRVL) shares hit a 52-week high of $23.35 and a 52-week low of $9.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.